156161-89-6
156161-89-6
Chemical Structure
BQ-788 sodium salt
- CAS No.: 156161-89-6
- Formula:C34H50N5NaO7
- Molecular Weight:663.78
IUPAC Name: sodium (R)-2-((R)-2-((S)-2-((2R,6S)-2,6-dimethylpiperidine-1-carboxamido)-4,4-dimethylpentanamido)-3-(1-(methoxycarbonyl)-1H-indol-3-yl)propanamido)hexanoate
InChIKey: QCVIFBRTTLMEOV-FUKQNADPSA-M
SMILES: CCCC[C@H](C(O[Na])=O)NC([C@@H](CC1=CN(C(OC)=O)C2=CC=CC=C12)NC([C@H](CC(C)(C)C)NC(N3[C@H](C)CCC[C@@H]3C)=O)=O)=O
Biological Activity: BQ-788 sodium salt is a potent and selective ETB receptor antagonist, inhibiting ET-1 binding to ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BQ-788 sodium salt | 99.33% | BQ-788 sodium salt is a potent and selective ETB receptor antagonist, inhibiting ET-1 binding to ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vodudeutentan sodium | Vodudeutentan sodium is a deuterated endothelin B receptor (ETBR) antagonist with no activity against human type A endothelin receptor (ETA). Vodudeutentan sodium can be incorporated into a controlled systemic release delivery system and can also be selectively combined with an additional antineoplastic agent. Vodudeutentan sodium is applicable to the research of urothelial carcinoma, bladder cancer and renal cell carcinoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.93
HY-15894ABQ-788 -
Similarity Score 0.57
HY-136785PD151242 -
Similarity Score 0.56
HY-135446BQ-610 -
Similarity Score 0.56
HY-102092FR139317 -
Similarity Score 0.54
HY-P2619BPP 5a -
Similarity Score 0.54
HY-135108QWF Peptide -
Similarity Score 0.53
HY-P2204PD-149163 -
Similarity Score 0.53
HY-P10029Sakura-6 -
Similarity Score 0.53
HY-P1614ZEP-3 -
Explore the MedChemAI to find more analogs
